HomeAI · summaries
Storia in 2 fonti
Axsome fends off generic competition to narcolepsy med Sunosi until 2040
With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. | The company inked another settlement with a prospective generic maker, leaving no further pending patent litigation for its Sunosi on the table.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Axsome pushes back generic entry for narcolepsy drug until 2040
Axsome has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040.
- ·
fiercepharma.com
Axsome fends off generic competition to narcolepsy med Sunosi until 2040
With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. | The company inked another…